Serotonergic mediation of DRL 72s behavior: Receptor subtype involvement in a behavioral screen for antidepressant drugs

Biological Psychiatry

Volumn 45, Issue 9, 1999, Pages 1151-1162

  Jolly, David C ^a   Richards, Jerry B ^a   Seiden, Lewis S ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

5,7 dihydroxytryptamine; Antidepressants; Behavioral screen; DRL; Serotonergic agonists

Indexed keywords

5 METHOXY N,N DIMETHYLTRYPTAMINE; 5,7 DIHYDROXYTRYPTAMINE; 8 HYDROXY 2 PROPYLAMINOTETRALIN; ANTIDEPRESSANT AGENT; BUSPIRONE; SEROTONIN; SEROTONIN AGONIST;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DEPRESSION; DRUG ACTIVITY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; REINFORCEMENT; SEROTONIN BRAIN LEVEL; SEROTONINERGIC TRANSMISSION;

5,7-DIHYDROXYTRYPTAMINE; 5-HYDROXYTRYPTOPHAN; 8-HYDROXY-2-(DI-N-PROPYLAMINO)TETRALIN; ANIMALS; ANTIDEPRESSIVE AGENTS; BEHAVIOR, ANIMAL; BRAIN; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; RATS; RATS, SPRAGUE-DAWLEY; REINFORCEMENT SCHEDULE; SEROTONIN; TIME FACTORS;

EID: 0033135032     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3223(98)00014-6     Document Type: Article

References (61)

1. Artigas F (1993): 5-HT and antidepressants: New views from microdialysis studies [letter; comment] [see comments]. Trends Pharmacol Sci, 14:262.
2. Artigas F. Pindolol, 5-hydroxytryptamine, and antidepressant augmentation. Arch Gen Psychiatry. 52:1995;969-971. [letter; comment].
3. Beasley C.M., Masica D.N., Potvin J.H. Fluoxetine A review of receptor and functional effects and their clinical implications . Psychopharmacology (Berl). 107:1992;1-10. [review].
4. Bizot J.C., Thiebot M.H., LeBihan C., Soubrie P., Simon P. Effects of imipramine-like drugs and serotonin uptake blockers on delay of reward of rats Possible implication in the behavioral mechanism of action of antidepressants . J Pharmacol Exp Ther. 246:1998;1144-1151.
5. Blier P., De Montigny C. Electrophysiological studies on the heterogeneity of 5-HT1A receptors Psychopharmacological implications . Clin Neuropharmacol. 15:(suppl 1):1992;137A-138A.
6. Blier P., De Montigny C. Current advances and trends in the treatment of depression. Trends Pharmacol Sci. 15:1994;220-226. [review; see comments].
7. Blier P., Lista A., De Montigny C. Differential properties of pre- and postsynaptic 5-hydroxytryptamine 1A receptors in the dorsal raphe and hippocampus: I. Effect of spiperone. J Pharmacol Exp Ther. 265:1993;7-15.
8. Deakin JF (1991): Depression and 5HT [review]. Int Clin Psychopharmacol 6(suppl 3):23-28 [discussion pp 29-31].
9. Deakin J.F., Pennell I., Upadhyaya A.J., Lofthouse R. A neuroendocrine study of 5HT function in depression Evidence for biological mechanisms of endogenous and psychosocial causation . Psychopharmacology (Berl). 101:1990;85-92.
10. Delgado P.L., Price L.H., Miller H.L., Salomon R.M., Aghajanian G.K., Heninger G.R., et al. Serotonin and the neurobiology of depression. Effects of tryptophan depletion in drug-free depressed patients. Arch Gen Psychiatry. 51:1994;865-874.
11. Detke M.J., Rickels M., Lucki I. Active behaviors in the rat forced swimming test differentially produced by serotonergic and noradrenergic antidepressants. Psychopharmacology (Berl). 121:1995;66-72.
12. Detke M.J., Wieland S., Lucki I. Blockade of the antidepressant-like effects of 8-OH-DPAT, buspirone and desipramine in the rat forced swim test by 5HT1A receptor antagonists. Psychopharmacology (Berl). 119:1995;47-54.
13. Dunn R.T., Richards J.B., Seiden L.S. Effects of salbutamol upon performance on an operant screen for antidepressants. Psychopharmacology (Berl). 113:1993;1-10.
14. Hadrava V., Blier P., Dennis T., Ortemann C., De Montigny C. Characterization of 5-hydroxytryptamine 1A properties of flesinoxan In vivo electrophysiology and hypothermia study . Neuropharmacology. 34:1995;1311-1326.
15. Heffner T.G., Hartman J.A., Seiden L.S. Rapid method for the regional dissection of the rat brain. Pharmacol Biochem Behav. 13:1980;453-456.
16. Jonas JM, Cohon MS (1993): A comparison of the safety and efficacy of alprazolam versus other agents in the treatment of anxiety, panic, and depression: A review of the literature [review]. J Clin Psychiatry 54(suppl:25-45 discussion pp 46-48].
17. Katz M.M., Maas J.W., Frazer A., Koslow S.H., Bowden C.L., Berman N., et al. Drug-induced actions on brain neurotransmitter systems and changes in the behaviors and emotions of depressed patients. Neuropsychopharmacology. 11:1994;89-100.
18. Koslow S.H., Maas J.W., Bowden C.L., Davis J.M., Hanin I., Javaid J. CSF and urinary biogenic amines and metabolites in depression and mania A controlled, univariate analysis . Arch Gen Psychiatry. 40:1983;999-1010.
19. Kotake C., Heffner T., Vosmer G., Seiden L. Determination of dopamine, norepinephrine, serotonin and their major metabolic products in rat brain by reverse-phase ion-pair high performance liquid chromatography with electrochemical detection. Pharm Biochem Behav. 22:1985;85-89.
20. Kreiss D.S., Lucki I. Desensitization of 5-HT1A autoreceptors by chronic administration of 8-OH-DPAT. Neuropharmacology. 31:1992;1073-1076.
21. Kreiss D.S., Lucki I. Differential regulation of serotonin (5-HT) release in the striatum and hippocampus by 5-HT1A autoreceptors of the dorsal and median raphe nuclei. J Pharmacol Exp Ther. 269:1994;1268-1279.
22. Kreiss D.S., Lucki I. Effects of acute and repeated administration of antidepressant drugs on extracellular levels of 5-hydroxytryptamine measured in vivo. J Pharmacol Exp Ther. 274:1995;866-876.
23. Launay J.M., Callebert J., Bondoux D., Loric S., Maroteaux L. Serotonin receptors and therapeutics. Cell Mol Bio. 40:1994;327-336. [review].
24. Lucki I. 5-HT1 receptors and behavior. Neurosci Biobehav Rev. 16:1992;83-93. [review].
25. Lucki I., Singh A., Kreiss D.S. Antidepressant-like behavioral effects of serotonin receptor agonists. Neurosci Biobehav Rev. 18:1994;85-95. [review].
26. Marek G.J., Li A.A., Seiden L.S. Antidepressant-like effects of (+)-oxaprotiline on a behavioral screen. Eur J Pharmacol. 157:1988;183-188.
27. Marek G.J., Li A.A., Seiden L.S. Selective 5-hydroxytryptamine2 antagonists have antidepressant-like effects on differential-reinforcement-of-low-rate 72-second schedule. J Pharmacol Exp Ther. 250:1989;52-59.
28. Marek G.J., Li A.A., Seiden L.S. Evidence for involvement of 5-hydroxytryptamine1 receptors in antidepressant-like drug effects on differential-reinforcement-of-low-rate 72-second behavior. J Pharmacol Exp Ther. 250:1989;60-71.
29. Marek G.J., Seiden L.S. Effects of selective 5-hydroxytryptamine-2 and nonselective 5-hydroxytryptamine antagonists on the differential-reinforcement-of-low-rate 72-second schedule. J Pharmacol Exp Ther. 244:1988;650-658.
30. Marek G.J., Seiden L.S. Effects of selective 5-hydroxytryptamine-2 and nonselective 5-hydroxytryptamine antagonists on the differential-reinforcement-of-low-rate 72-second schedule. J Pharmacol Exp Ther. 244:1988;650-658.
31. McGrath P.J., Stewart J.W., Quitkin F.M., Wager S., Jenkins S.W., Archibald D.G., et al. Gepirone treatment of atypical depression Preliminary evidence of serotonergic involvement . J Clin Psychopharmacol. 14:1994;347-352.
32. McGuire P.S., Seiden L.S. The effects of tricyclic antidepressants on performance under a differential-reinforcement-of-low-rates schedule in rats. J Pharmacol Exp Ther. 214:1980;635-641.
33. McGuire P.S., Seiden L.S. Differential effects of imipramine in rats as a function of DRL schedule value. Pharmacol Biochem Behav. 13:1980;691-694.
34. O'Donnell J.M. Effects of clenbuterol and prenalterol on performance during differential reinforcement of low response rate in the rat. J Pharmacol Exp Ther. 241:1987;68-75.
35. O'Donnell J.M. Antidepressant-like effects of rolipram and other inhibitors of cyclic adenosine monophosphate phosphodiesterase on behavior maintained by differential reinforcement of low response rate. J Pharmacol Exp Ther. 264:1993;1168-1178.
36. O'Donnell J.M. Effects of the beta-2 adrenergic agonist zinterol on DRL behavior and locomotor activity. Psychopharmacology (Berl). 113:1993;89-94.
37. O'Donnell J.M., Seiden L.S. Effects of monoamine oxidase inhibitors on performance during differential reinforcement of low response rate. Psychopharmacology (Berl). 78:1982;214-218.
38. O'Donnell J.M., Seiden L.S. Differential-reinforcement-of-low-rate 72-second schedule Selective effects of antidepressant drugs . J Pharmacol Exp Ther. 224:1983;80-88.
39. O'Donnell J.M., Seiden L.S. Altered effects of desipramine on operant performance after 6-hydroxydopamine-induced depletion of brain dopamine or norepinephrine. J Pharmacol Exp Ther. 229:1984;629-635.
40. O'Donnell J.M., Seiden L.S. Effect of the experimental antidepressant AHR-9377 on performance during differential reinforcement of low response rate. Psychopharmacology (Berl). 87:1985;283-285.
41. O'Donnell J.M., Frith S., Wilkins J. Involvement of beta-1 and beta-2 adrenergic receptors in the antidepressant-like effects of centrally administered isoproterenol. J Pharmacol Exp Ther. 271:1994;246-254.
42. Paxinos G, Watson C (1986): The Rat Brain in Stereotaxic Coordinates. Orlando, FL.
43. Pollard G.T., Howard J.L. Similar effects of antidepressant and non-antidepressant drugs on behavior under an interresponse-time greater than 72-s schedule. Psychopharmacology (Berl). 89:1986;253-258.
44. Porsolt R.D., Anton G., Blavet N., Jalfre M. Behavioural despair in rats A new model sensitive to antidepressant treatments . Eur J Pharmacol. 47:1978;379-391.
45. Richards J.B., Seiden L.S. A quantitative interresponse-time analysis of DRL performance differentiates similar effects of the antidepressant desipramine and the novel anxiolytic gepirone. J Exp Anal Behav. 56:1991;173-192.
46. Richards J.B., Sabol K.E., Seiden L.S. DRL interresponse-time distributions Quantification by peak deviation analysis . J Exp Anal Behav. 60:1993;361-385.
47. Richards R.B., Sabol K.E., Hand T.H., Jolly D.C., Marek G.J., Seiden L.S. Buspirone, gepirone, ipsapirone, and zalospirone have unique effects on the differential-reinforcement-of-low-rate 72-second schedule when compared to 5-HTP and diazepam. Psychopharmacology (Berl). 114:1994;39-46.
48. Richards J.B., Sabol K.E., Layton K.E., Seiden L.S. 5HT depletion causes deficits in waiting behavior but not timing. Soc Neurosci Abs. 20:1994;378.
49. Scott P.A., Chou J.M., Tang H., Frazer A. Differential induction of 5-HT1A-mediated responses in vivo by three chemically dissimilar 5-HT1A agonists. J Pharmacol Exp Ther. 270:1994;198-208.
50. Seiden L.S., Dahms J.L., Shaughnessy R.A. Behavioral screen for antidepressants The effects of drugs and electroconvulsive shock on performance under a differential-reinforcement-of-low-rate schedule . Psychopharmacology (Berl). 86:1985;55-60.
51. Seiden L.S., Marek G., O'Donnell J.M., Li A., Dunn R., Jolly D. Role of noradrenergic and serotonergic systems in the screening of antidepressant drugs. Belmaker R.H., Sandler M., Dahlstrom A. Progress in Catecholamine Research. 1987;337-342 Liss, New York.
52. Seletti B., Benkelfat C., Blier P., Annable L., Gilbert F., De Montigny C. Serotonin 1A receptor activation by flesinoxan in humans. Body temperature and neuroendocrine responses. Neuropsychopharmacology. 13:1995;93-104.
53. Singh A., Lucki I. Antidepressant-like activity of compounds with varying efficacy at 5-HT1A receptors. Neuropharmacology. 32:1993;331-340.
54. Stahl S.M. Serotonergic mechanisms and the new antidepressants. Psychol Med. 23:1993;281-285. [editorial; review].
55. Sussman N (1993): How to manage anxious patients who are depressed [review]. J Clin Psychiatry, 54(supp)l:8-16, [discussion pp 17-20].
56. Sussman N. The potential benefits of serotonin receptor-specific agents. J Clin Psychiatry. 55:(suppl):1994;45-51. [review].
57. Virkkunen M., Goldman D., Nielsen D.A., Linnoila M. Low brain serotonin turnover rate (low CSF 5-HIAA) and impulsive violence. J Psychiatry Neurosci. 20:1995;271-275. [review].
58. Wieland S., Fischette C.T., Lucki I. Effect of chronic treatments with tandospirone and imipramine on serotonin-mediated behavioral responses and monoamine receptors. Neuropharmacology. 32:1993;561-573.
59. Willner P. Animal models of depression Validity and applications . Adv Biochem Psychopharmacol. 49:1995;19-41. [review].
60. Winer B.J. Statistical Principles in Experimental Design. 1971;McGraw-Hill, New York.
61. Yunger L.M., Harvey J.A. Kinetic analysis of 3H-serotonin accumulation in four regions of rat brain after lesions in the medial forebrain bundle. Life Sci. 19:1976;105-115.